Exact Therapeutics (Norway) Analysis
| EXTX Stock | NOK 3.40 0.06 1.73% |
Exact Therapeutics AS is fairly valued with Real Value of 3.36 and Hype Value of 3.4. The main objective of Exact Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Exact Therapeutics AS is worth, separate from its market price. There are two main types of Exact Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Exact Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Exact Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Exact Therapeutics stock is traded in Norway on Oslo Stock Exchange, with the market opening at 09:00:00 and closing at 16:20:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Norway.
Exact |
Exact Stock Analysis Notes
About 64.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.95. Exact Therapeutics had not issued any dividends in recent years. The entity had 250:1 split on the 27th of July 2020. EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway. To learn more about Exact Therapeutics AS check out https://www.exact-tx.com.Exact Therapeutics Investment Alerts
| Exact Therapeutics generated a negative expected return over the last 90 days | |
| Exact Therapeutics has high historical volatility and very poor performance | |
| Exact Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (58.59 M) with profit before overhead, payroll, taxes, and interest of 52 K. | |
| Exact Therapeutics generates negative cash flow from operations | |
| About 64.0% of the company shares are held by company insiders |
Exact Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 359.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Exact Therapeutics's market, we take the total number of its shares issued and multiply it by Exact Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 19th of January, Exact Therapeutics shows the Coefficient Of Variation of (941.93), mean deviation of 2.94, and Standard Deviation of 5.73. Exact Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Exact Therapeutics information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Exact Therapeutics is priced favorably, providing market reflects its regular price of 3.4 per share.Exact Therapeutics Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Exact Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Exact Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Exact Therapeutics Outstanding Bonds
Exact Therapeutics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Exact Therapeutics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Exact bonds can be classified according to their maturity, which is the date when Exact Therapeutics AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Exact Therapeutics Predictive Daily Indicators
Exact Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Exact Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Exact Therapeutics Forecast Models
Exact Therapeutics' time-series forecasting models are one of many Exact Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Exact Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Exact Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Exact Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Exact shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Exact Therapeutics. By using and applying Exact Stock analysis, traders can create a robust methodology for identifying Exact entry and exit points for their positions.
EXACT Therapeutics AS, a clinical stage biotech company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy . The company was founded in 2012 and is based in Oslo, Norway. EXACT THERAPEUTICS is traded on Oslo Stock Exchange in Norway.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Exact Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Other Information on Investing in Exact Stock
Exact Therapeutics financial ratios help investors to determine whether Exact Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Exact with respect to the benefits of owning Exact Therapeutics security.